Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12095052 | 1.00 | RORC (0.34) | RORCTSHRGABRA1GABRG2GABRB3 | |
| SCHEMBL16985214 | 0.91 | ABHD6 (0.33) | RORCGABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL17972685 | 0.90 | RORC (0.36) | RORCTSHRGABRA1GABRG2GABRB3 | |
| SCHEMBL20279553 | 0.83 | — | — | |
| SCHEMBL6441894 | 0.83 | — | — | |
| SCHEMBL20278919 | 0.83 | — | — | |
| SCHEMBL20235876 | 0.82 | ALDH1A1 (0.48) | — | |
| SCHEMBL701889 | 0.81 | TSHR (0.32) | RORCTSHRGABRA1GABRG2GABRB3 | |
| SCHEMBL8760081 | 0.81 | TSHR (0.50) | RORCTSHRGABRA1GABRG2GABRB3 | |
| SCHEMBL92811 | 0.81 | TSHR (0.50) | RORCTSHRGABRA1GABRG2GABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 651 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118117169-B | Special additive for electrolyte, electrolyte and lithium ion battery | TIANMU LAKE INSTITUTE OF ADVANCED ENERGY STORAGE TECHNOLOGIES Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| WO-2026102734-A1 | SOLID-STATE ELECTROLYTE, PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳理工大学 | 2026-05-21 | — | — | WO | claimed |
| CN-122051430-A | Solid electrolyte and preparation method and application thereof | 深圳理工大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122051382-A | Electrolyte and lithium ion battery | 远景动力技术(江苏)有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122025825-A | Electrolyte, battery and electricity utilization device | 广州汽车集团股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260106221-A1 | LITHIUM SECONDARY BATTERY WITH ENHANCED SAFETY | SOLVAY SPECIALTY POLYMERS IT (IT) | 2026-04-16 | — | — | US | claimed |
| US-20250357553-A1 | LITHIUM ION SECONDARY BATTERY AND MANUFACTURING METHOD THEREOF | LG ENERGY SOLUTION LTD (KR) | 2025-11-20 | — | — | US | claimed |
| US-20250357543-A1 | ELECTROLYTES INCLUDING FLUORINATED ORGANIC SOLVENT MIXTURES FOR BATTERIES INCLUDING HIGH-VOLTAGE POSITIVE ELECTRODE MATERIALS AND BATTERIES INCLUDING THE SAME | GM GLOBAL TECH OPERATIONS LLC (US) | 2025-11-20 | — | — | US | claimed |
| EP-4602667-A1 | LITHIUM SECONDARY BATTERY WITH ENHANCED SAFETY | Solvay Specialty Polymers Italy S.p.A. (IT) | 2025-08-20 | — | — | EP | claimed |
| CN-119742456-B | Electrolyte for solving needling problem of battery cell and preparation method | 江苏传艺钠电科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| US-8765993-B2 | One-pot production of carbamates using solid catalysts | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2014-07-01 | — | — | US | claimed |
| EP-2736112-A2 | NONAQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY USING SAME | LG Chem, Ltd. (KR) | 2014-05-28 | — | — | EP | claimed |
| US-8735621-B2 | Preparation of carbamates with solid catalysts | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2014-05-27 | — | — | US | claimed |
| US-20130252113-A1 | NON-AQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY USING THE SAME | LG CHEM, LTD. (KR) | 2013-09-26 | — | — | US | claimed |
| US-20120053359-A1 | ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS | UNIVERSIDAD POLITECNICA DE VALENCIA (ES) | 2012-03-01 | — | — | US | claimed |
| EP-2407449-A1 | ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS | Consejo Superior de Investigaciones Científicas (CSIC) (ES) | 2012-01-18 | — | — | EP | claimed |
| US-20110124902-A1 | PREPARATION OF CARBAMATES WITH SOLID CATALYSTS | Consejo Superior De Investigaciones Cientificas C/Serrano, 117 (ES) | 2011-05-26 | — | — | US | claimed |
| EP-2316822-A1 | PREPARATION OF CARBAMATES WITH SOLID CATALYSTS | Consejo Superior De Investigaciones Científicas (ES) | 2011-05-04 | — | — | EP | claimed |
| US-20090082588-A1 | Process for producing fluorinated carbamates and isocyanates | REPSOL YPF, S.A. (ES) | 2009-03-26 | — | — | US | claimed |
| EP-2036884-A1 | Process for producing fluorinated isocyanates and carbamates | REPSOL YPF S.A. (ES) | 2009-03-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260106221-A1 | LITHIUM SECONDARY BATTERY WITH ENHANCED SAFETY | BCL6B, CLCN2, SLC9A2 | RORC 855/4885TSHR 498/4885GABRA1 1920/4885 |
| US-20120053359-A1 | ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS | CA7, CA2, CA4 | RORC 3523/4885TSHR 3643/4885GABRA1 2081/4885 |
| US-20110124902-A1 | PREPARATION OF CARBAMATES WITH SOLID CATALYSTS | ODC1, RCC1, OTC | RORC 3908/4885TSHR 4777/4885GABRA1 4278/4885 |
| US-20090082588-A1 | Process for producing fluorinated carbamates and isocyanates | SRM, CA4, PRMT3 | RORC 4583/4885TSHR 2447/4885GABRA1 3277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.